pyrazines has been researched along with HIV Coinfection in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 10 (66.67) | 24.3611 |
| 2020's | 2 (13.33) | 2.80 |
| Authors | Studies |
|---|---|
| Abhang, K; Asgaonkar, KD; Bakhle, B; Chitre, TS; Khater, A; Patil, SM; Singh, M | 1 |
| Aldon, Y; Armanasco, N; Harman, S; Herrera, C; Nuttall, J; Rogers, P; Shattock, RJ; Stieh, D; Ziprin, P | 1 |
| Cicalini, S; D'Abbraccio, M; d'Ettorre, G; Di Biagio, A; Maggi, P; Martinelli, C; Nunnari, G; Rusconi, S; Sighinolfi, L; Spagnuolo, V; Squillace, N | 1 |
| Sekhar, RV | 1 |
| Best, C; Laciny, E; Reeds, DN; Royal, M; Struthers, H; Yarasheski, KE | 1 |
| Carbone, A; Gloghini, A; Spina, M; Tirelli, U | 1 |
| Alba, L; Antinori, A; Bibas, M; Del Nonno, F; Grisetti, S; Picchi, G | 1 |
| Andrei, G; Balzarini, J; Camarasa, MJ; de Castro, S; Familiar, O; Snoeck, R; Velázquez, S | 1 |
| Bhagat, G; Bongero, D; Lipstein, M; Montanari, F; O'Connor, O; Paoluzzi, L | 1 |
| Colby-Germinario, SP; Ibanescu, RI; Mespléde, T; Moisi, D; Oliveira, M; Quashie, PK; Schader, SM; Wainberg, MA | 1 |
| Baiga, TJ; Elleder, D; Hughes, SH; Naughton, JA; Noel, JP; Russell, RL; Young, JA | 1 |
| Goodwin, SR; Laciny, E; Reeds, DN; Royal, M; Struthers, H; Yarasheski, KE | 1 |
| Aliabadi, N; Breu, J; Grinspoon, S; Hadigan, C; Meininger, G; Rabe, J | 1 |
| Alvarez, S; Barrero, M; Cabrero, JR; Fernández, G; Gordon-Alonso, M; Muñoz-Fernández, MA; Naranjo-Suárez, S; Sánchez-Madrid, F; Serrador, JM; Ursa, A; Valenzuela-Fernández, A; Yáñez-Mo, M | 1 |
| Andersen, R; Grinspoon, S; Hadigan, C; Liebau, J; Torriani, M | 1 |
3 review(s) available for pyrazines and HIV Coinfection
| Article | Year |
|---|---|
Cardiovascular risk and dyslipidemia among persons living with HIV: a review.
Topics: Anti-HIV Agents; Cardiovascular Diseases; Cholesterol; Dyslipidemias; Growth Hormone-Releasing Hormone; HIV Infections; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Lipodystrophy; Pyrazines; Risk Factors | 2017 |
Treatment of dyslipidemia in HIV.
Topics: Anti-HIV Agents; Anticholesteremic Agents; Azetidines; Cholesterol, HDL; Cholesterol, LDL; Diet Therapy; Dyslipidemias; Exercise Therapy; Ezetimibe; Fatty Acids, Nonesterified; Fatty Acids, Omega-3; Fibric Acids; Glutathione; Growth Hormone-Releasing Hormone; HIV Infections; Human Growth Hormone; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Leptin; Niacin; Pyrazines; Thiazolidinediones; Triglycerides | 2015 |
Therapeutic options for HIV-associated lymphomas.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Boronic Acids; Bortezomib; Epstein-Barr Virus Infections; HIV Infections; Humans; Lymphoma, AIDS-Related; Lymphoma, Large B-Cell, Diffuse; Pyrazines; Rituximab; Treatment Outcome | 2010 |
4 trial(s) available for pyrazines and HIV Coinfection
| Article | Year |
|---|---|
Sitagliptin Reduces Inflammation and Chronic Immune Cell Activation in HIV+ Adults With Impaired Glucose Tolerance.
Topics: Adipokines; Adult; Chemokines; Endothelial Progenitor Cells; Female; Glucose Intolerance; HIV Infections; HIV-1; Humans; Hypoglycemic Agents; Inflammation; Lymphocyte Activation; Male; Middle Aged; Pyrazines; Sitagliptin Phosphate; Triazoles | 2015 |
Dipeptidyl peptidase IV inhibition does not adversely affect immune or virological status in HIV infected men and women: a pilot safety study.
Topics: Adolescent; Adult; Aged; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Female; HIV Infections; HIV Seropositivity; Humans; Male; Middle Aged; Pilot Projects; Pyrazines; RNA, Viral; Sitagliptin Phosphate; Triazoles | 2013 |
Inhibition of lipolysis improves insulin sensitivity in protease inhibitor-treated HIV-infected men with fat redistribution.
Topics: Adipose Tissue; Adult; Area Under Curve; Fasting; Fatty Acids; Glucose Tolerance Test; HIV Infections; Humans; Hyperinsulinism; Hypolipidemic Agents; Insulin Resistance; Lipodystrophy; Lipolysis; Male; Middle Aged; Protease Inhibitors; Pyrazines; Viscera | 2003 |
Improved triglycerides and insulin sensitivity with 3 months of acipimox in human immunodeficiency virus-infected patients with hypertriglyceridemia.
Topics: Adult; Body Composition; Double-Blind Method; Fatty Acids, Nonesterified; Female; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Insulin; Insulin Resistance; Male; Middle Aged; Placebos; Pyrazines; Triglycerides | 2006 |
8 other study(ies) available for pyrazines and HIV Coinfection
| Article | Year |
|---|---|
In Search of HIV Entry Inhibitors Using Molecular Docking, ADME, and Toxicity Studies of Some Thiazolidinone-Pyrazine Derivatives Against CXCR4 Co-receptor.
Topics: HIV Fusion Inhibitors; HIV Infections; Humans; Molecular Docking Simulation; Pyrazines; Receptors, CXCR4 | 2022 |
The entry inhibitor DS003 (BMS-599793): a BMS-806 analogue, provides superior activity as a pre-exposure prophylaxis candidate.
Topics: CD4 Antigens; HIV Envelope Protein gp120; HIV Fusion Inhibitors; HIV Infections; Humans; Piperazines; Piperidines; Pre-Exposure Prophylaxis; Pyrazines | 2021 |
Patient with HIV-associated plasmablastic lymphoma responding to bortezomib alone and in combination with dexamethasone, gemcitabine, oxaliplatin, cytarabine, and pegfilgrastim chemotherapy and lenalidomide alone.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Boronic Acids; Bortezomib; Cytarabine; Deoxycytidine; Dexamethasone; Filgrastim; Gemcitabine; Granulocyte Colony-Stimulating Factor; HIV Infections; Humans; Lenalidomide; Lymphoma, Large-Cell, Immunoblastic; Male; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Polyethylene Glycols; Pyrazines; Recombinant Proteins; Thalidomide; Young Adult | 2010 |
From β-amino-γ-sultone to unusual bicyclic pyridine and pyrazine heterocyclic systems: synthesis and cytostatic and antiviral activities.
Topics: Amines; Antiviral Agents; Cells, Cultured; Cytostatic Agents; Heterocyclic Compounds, 2-Ring; HIV Infections; HIV-1; Pyrazines; Pyridines; Structure-Activity Relationship; Sulfones; Virus Replication | 2011 |
Bortezomib-induced tumor lysis syndrome in a patient with HIV-negative plasmablastic lymphoma.
Topics: Aged; Antineoplastic Agents; Boronic Acids; Bortezomib; HIV Infections; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Pyrazines; Tumor Lysis Syndrome | 2010 |
HIV gp120 H375 is unique to HIV-1 subtype CRF01_AE and confers strong resistance to the entry inhibitor BMS-599793, a candidate microbicide drug.
Topics: Amino Acid Sequence; Anti-HIV Agents; Antibodies, Neutralizing; Cell Line, Tumor; Drug Resistance, Viral; Genes, env; Genotype; HIV Antibodies; HIV Envelope Protein gp120; HIV Infections; HIV-1; HIV-2; Humans; Models, Molecular; Mutagenesis, Site-Directed; Piperidines; Polymorphism, Genetic; Protein Structure, Quaternary; Pyrazines; Sequence Alignment; Virus Internalization | 2012 |
Identification of a 3-aminoimidazo[1,2-a]pyridine inhibitor of HIV-1 reverse transcriptase.
Topics: Anti-HIV Agents; Drug Evaluation, Preclinical; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Imidazoles; Pyrazines; Reverse Transcriptase Inhibitors; Small Molecule Libraries | 2012 |
Histone deacetylase 6 regulates human immunodeficiency virus type 1 infection.
Topics: Acetylation; Aminobenzoates; CD4-Positive T-Lymphocytes; Cell Fusion; Cell Line, Tumor; Gene Silencing; HeLa Cells; Histone Deacetylase 6; Histone Deacetylases; HIV Envelope Protein gp120; HIV Infections; HIV-1; Humans; Hydroxamic Acids; Jurkat Cells; Pyrazines; RNA, Small Nuclear; Transfection; Tubulin | 2005 |